Teva gets FDA approval for cancer drug

(Reuters) - Israel's Teva Pharmaceutical Industries said the U.S. Food and Drug Administration approved an injectable and infusion version of its cancer drug bendamustine.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news